NanoVibronix, Inc. (NAOV)
USD 2.32
(-9.38%)
USD 2.32
(-9.38%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -3.43 Million USD | 32.18% |
| 2022 | -5.01 Million USD | 31.14% |
| 2021 | -14.24 Million USD | -55.95% |
| 2020 | -4.16 Million USD | 15.15% |
| 2019 | -5.74 Million USD | -30.04% |
| 2018 | -4.27 Million USD | -36.19% |
| 2017 | -3.63 Million USD | -35.07% |
| 2016 | -2.69 Million USD | -27.69% |
| 2015 | -2.37 Million USD | 12.46% |
| 2014 | -1.33 Million USD | -27.7% |
| 2013 | -1.23 Million USD | -61.19% |
| 2012 | -1.01 Million USD | -45.95% |
| 2011 | -692 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -673 Thousand USD | -18.54% |
| 2024 Q1 | -568 Thousand USD | 19.12% |
| 2023 Q2 | -1.02 Million USD | 3.02% |
| 2023 Q1 | -1.06 Million USD | 39.84% |
| 2023 Q3 | -670 Thousand USD | 34.82% |
| 2023 Q4 | -702 Thousand USD | -4.78% |
| 2023 FY | - USD | 32.18% |
| 2022 Q1 | -1.11 Million USD | 56.01% |
| 2022 Q2 | -1.26 Million USD | -14.03% |
| 2022 Q3 | -923 Thousand USD | 27.21% |
| 2022 Q4 | -1.76 Million USD | -90.9% |
| 2022 FY | - USD | 31.14% |
| 2021 Q1 | 635 Thousand USD | 164.47% |
| 2021 Q3 | -891 Thousand USD | 49.4% |
| 2021 Q4 | -2.52 Million USD | -183.73% |
| 2021 Q2 | -1.76 Million USD | -377.32% |
| 2021 FY | - USD | -55.95% |
| 2020 Q4 | -985 Thousand USD | -22.51% |
| 2020 Q2 | -1.46 Million USD | -62.03% |
| 2020 FY | - USD | 15.15% |
| 2020 Q1 | -906 Thousand USD | 50.65% |
| 2020 Q3 | -804 Thousand USD | 45.23% |
| 2019 Q1 | -2.22 Million USD | -66.02% |
| 2019 FY | - USD | -30.04% |
| 2019 Q4 | -1.83 Million USD | -131.82% |
| 2019 Q3 | -792 Thousand USD | -11.08% |
| 2019 Q2 | -713 Thousand USD | 67.93% |
| 2018 Q3 | -1.32 Million USD | -60.8% |
| 2018 FY | - USD | -36.19% |
| 2018 Q1 | -788 Thousand USD | 51.33% |
| 2018 Q2 | -824 Thousand USD | -4.57% |
| 2018 Q4 | -1.33 Million USD | -1.06% |
| 2017 FY | - USD | -35.07% |
| 2017 Q1 | -800 Thousand USD | 35.38% |
| 2017 Q2 | -656 Thousand USD | 18.0% |
| 2017 Q3 | -612 Thousand USD | 6.71% |
| 2017 Q4 | -1.61 Million USD | -164.54% |
| 2016 Q1 | -472 Thousand USD | 74.14% |
| 2016 FY | - USD | -27.69% |
| 2016 Q4 | -1.23 Million USD | -127.99% |
| 2016 Q3 | -543 Thousand USD | -19.6% |
| 2016 Q2 | -454 Thousand USD | 3.81% |
| 2015 FY | - USD | 12.46% |
| 2015 Q1 | -309 Thousand USD | 76.1% |
| 2015 Q2 | -312 Thousand USD | -0.97% |
| 2015 Q3 | -336 Thousand USD | -7.69% |
| 2015 Q4 | -1.82 Million USD | -443.15% |
| 2014 Q4 | -1.29 Million USD | -151.07% |
| 2014 FY | - USD | -27.7% |
| 2014 Q1 | -142 Thousand USD | 80.11% |
| 2014 Q2 | -267 Thousand USD | -88.03% |
| 2014 Q3 | -515 Thousand USD | -92.88% |
| 2013 Q4 | -714 Thousand USD | -262.44% |
| 2013 Q3 | -197 Thousand USD | 0.0% |
| 2013 FY | - USD | -61.19% |
| 2013 Q1 | -659 Thousand USD | -92.13% |
| 2012 FY | - USD | -45.95% |
| 2012 Q4 | -343 Thousand USD | -36.11% |
| 2012 Q3 | -252 Thousand USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | 74.531% |
| Cerus Corporation | -26.53 Million USD | 87.055% |
| OrthoPediatrics Corp. | -8.38 Million USD | 59.014% |
| PetVivo Holdings, Inc. | -10.49 Million USD | 67.269% |
| Talis Biomedical Corporation | -66.04 Million USD | 94.799% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | 79.4% |
| Inogen, Inc. | -45.67 Million USD | 92.48% |
| Spectral AI, Inc. | -12.26 Million USD | 71.987% |
| Nano-X Imaging Ltd. | -47.69 Million USD | 92.798% |
| CVRx, Inc. | -38.73 Million USD | 91.131% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 2.636% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | 71.628% |
| Orthofix Medical Inc. | -86.98 Million USD | 96.051% |
| Venus Concept Inc. | -26.11 Million USD | 86.846% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | 93.098% |
| Bioventus Inc. | -23.07 Million USD | 85.111% |
| BrainsWay Ltd. | -2.31 Million USD | -48.637% |
| Envoy Medical, Inc. | -18.23 Million USD | 81.166% |
| electroCore, Inc. | -17.76 Million USD | 80.659% |
| IceCure Medical Ltd | -15.25 Million USD | 77.48% |
| Lucid Diagnostics Inc. | -49.75 Million USD | 93.096% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | 79.621% |
| MaxCyte, Inc. | -44.12 Million USD | 92.216% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | 70.781% |
| Nexalin Technology, Inc. | -5.69 Million USD | 39.653% |
| PAVmed Inc | -75.74 Million USD | 95.465% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | 93.61% |
| RxSight, Inc. | -41.03 Million USD | 91.63% |
| Sight Sciences, Inc. | -49.41 Million USD | 93.049% |
| SI-BONE, Inc. | -34.44 Million USD | 90.028% |
| TELA Bio, Inc. | -40.63 Million USD | 91.546% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | 94.108% |
| Treace Medical Concepts, Inc. | -39 Million USD | 91.194% |
| LivaNova PLC | 39.01 Million USD | 108.804% |
| 908 Devices Inc. | -34.02 Million USD | 89.904% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 96.894% |
| Nemaura Medical Inc. | -7.28 Million USD | 52.862% |
| NeuroPace, Inc. | -22.83 Million USD | 84.957% |
| LENSAR, Inc. | -8.71 Million USD | 60.581% |
| Apyx Medical Corporation | -18.11 Million USD | 81.035% |
| Cutera, Inc. | -136.56 Million USD | 97.485% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -1.627% |
| BioSig Technologies, Inc. | -28.15 Million USD | 87.798% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 236.526% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | 83.634% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 100.896% |
| Axonics, Inc. | 7.77 Million USD | 144.18% |
| Outset Medical, Inc. | -153.78 Million USD | 97.766% |
| IRIDEX Corporation | -7.44 Million USD | 53.88% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 96.498% |
| IRadimed Corporation | 20.8 Million USD | 116.514% |
| Tivic Health Systems, Inc. | -8.06 Million USD | 57.393% |
| INVO Bioscience, Inc. | -6.88 Million USD | 50.073% |
| Telesis Bio, Inc. | -40.49 Million USD | 91.517% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 109.366% |
| Varex Imaging Corporation | 67.2 Million USD | 105.112% |
| Quipt Home Medical Corp. | 44.07 Million USD | 107.794% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 68.399% |
| Pulmonx Corporation | -55.09 Million USD | 93.765% |
| Dynatronics Corporation | -976 Thousand USD | -251.944% |
| Modular Medical, Inc. | -17.1 Million USD | 79.916% |
| ReShape Lifesciences Inc. | -14.48 Million USD | 76.286% |
| Semler Scientific, Inc. | 23.58 Million USD | 114.562% |
| InMode Ltd. | 196.28 Million USD | 101.75% |
| Bruker Corporation | 599 Million USD | 100.573% |
| Cytosorbents Corporation | -28.81 Million USD | 88.077% |
| DexCom, Inc. | 916.7 Million USD | 100.375% |
| Align Technology, Inc. | 799.03 Million USD | 100.43% |
| Viveve Medical, Inc. | -20.61 Million USD | 83.339% |
| ZimVie Inc. | 91.07 Million USD | 103.772% |
| Movano Inc. | -29.12 Million USD | 88.206% |
| Cytek Biosciences, Inc. | -4.4 Million USD | 22.073% |
| Nexalin Technology, Inc. | -5.69 Million USD | 39.653% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 2.636% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 98.235% |
| Profound Medical Corp. | -27.12 Million USD | 87.336% |
| Insulet Corporation | 323.6 Million USD | 101.061% |
| enVVeno Medical Corporation | -25.01 Million USD | 86.27% |
| Surmodics, Inc. | 1.18 Million USD | 389.141% |
| iCAD, Inc. | -6.56 Million USD | 47.677% |
| Nuwellis, Inc. | -16.35 Million USD | 78.999% |
| Biotricity, Inc. | -8.82 Million USD | 61.091% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 96.454% |
| Aethlon Medical, Inc. | -11.84 Million USD | 71.01% |
| InspireMD, Inc. | -20.91 Million USD | 83.573% |
| PAVmed Inc. | -75.74 Million USD | 95.465% |
| BIOLASE, Inc. | -15.13 Million USD | 77.31% |
| Beyond Air, Inc. | -59.03 Million USD | 94.181% |
| FONAR Corporation | 28.25 Million USD | 112.159% |
| AxoGen, Inc. | -13.32 Million USD | 74.227% |
| Vivani Medical, Inc. | -26.6 Million USD | 87.09% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 113.997% |
| Inari Medical, Inc. | 7.11 Million USD | 148.292% |
| UFP Technologies, Inc. | 72.74 Million USD | 104.722% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -1.454% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | 44.201% |
| Tenon Medical, Inc. | -15.52 Million USD | 77.879% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | 77.499% |
| Co-Diagnostics, Inc. | -41.47 Million USD | 91.718% |
| AdaptHealth Corp. | -171.09 Million USD | 97.992% |
| Sintx Technologies, Inc. | -6.6 Million USD | 47.955% |
| Quanterix Corporation | -38.08 Million USD | 90.981% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | 68.399% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 11550.0% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 98.761% |
| TransMedics Group, Inc. | -7.6 Million USD | 54.82% |
| ReWalk Robotics Ltd. | -21.76 Million USD | 84.218% |
| NeuroMetrix, Inc. | -7.09 Million USD | 51.591% |
| Hyperfine, Inc. | -47.06 Million USD | 92.701% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | 94.109% |
| Biomerica, Inc. | -5.99 Million USD | 42.683% |
| Bone Biologics Corporation | 479.57 Thousand USD | 816.264% |
| AVITA Medical, Inc. | -39.56 Million USD | 91.319% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | 62.553% |
| Silk Road Medical, Inc | -45.08 Million USD | 92.38% |